Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $162.0100 (-0.75%) ($158.0200 - $163.4800) on Wed. Mar. 28, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.92% (three month average) | RSI | 37 | Latest Price | $162.0100(-0.75%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.6% a day on average for past five trading days. | Weekly Trend | LGND declines -4.2% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Rotation from growth to value for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(60%) IWO(57%) XBI(56%) IWC(54%) IWM(53%) | Factors Impacting LGND price | LGND will decline at least -0.96% in a week (0% probabilities). TLT(-15%) VIXM(-14%) UUP(-8%) GDXJ(-6%) IGOV(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.96% (StdDev 1.92%) | Hourly BBV | 0 () | Intraday Trend | -0.9% | | | |
|
Resistance Level | $168.52 | 5 Day Moving Average | $163.45(-0.88%) | 10 Day Moving Average | $166.76(-2.85%) | 20 Day Moving Average | $168.52(-3.86%) | To recent high | -11.3% | To recent low | 18.3% | Market Cap | $2.604b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |